Page last updated: 2024-10-31

mitotane and Growth Disorders

mitotane has been researched along with Growth Disorders in 3 studies

Mitotane: A derivative of the insecticide DICHLORODIPHENYLDICHLOROETHANE that specifically inhibits cells of the adrenal cortex and their production of hormones. It is used to treat adrenocortical tumors and causes CNS damage, but no bone marrow depression.

Growth Disorders: Deviations from the average values for a specific age and sex in any or all of the following: height, weight, skeletal proportions, osseous development, or maturation of features. Included here are both acceleration and retardation of growth.

Research Excerpts

ExcerptRelevanceReference
"Mitotane was increased to 2."1.31Long-term (15 years) outcome in an infant with metastatic adrenocortical carcinoma. ( De León, DD; Lange, BJ; Moshang, T; Walterhouse, D, 2002)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
De León, DD1
Lange, BJ1
Walterhouse, D1
Moshang, T1
Raux-Demay, MC1
Girard, F1
Senior, B1

Reviews

1 review available for mitotane and Growth Disorders

ArticleYear
[Cushing syndrome in children].
    Annales de pediatrie, 1993, Volume: 40, Issue:7

    Topics: Adolescent; Adrenal Cortex Hormones; Adrenal Gland Neoplasms; Adrenalectomy; Adrenocorticotropic Hor

1993

Other Studies

2 other studies available for mitotane and Growth Disorders

ArticleYear
Long-term (15 years) outcome in an infant with metastatic adrenocortical carcinoma.
    The Journal of clinical endocrinology and metabolism, 2002, Volume: 87, Issue:10

    Topics: Adrenal Cortex Neoplasms; Antineoplastic Agents, Hormonal; Carcinoma; Cortodoxone; Growth Disorders;

2002
Cessation of growth.
    Hospital practice, 1978, Volume: 13, Issue:1

    Topics: Adolescent; Cushing Syndrome; Diagnosis, Differential; Growth Disorders; Humans; Mitotane; Turner Sy

1978